Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
M
A Study of N-Acetylcysteine (N-AC)in People Receiving CAR T-cell Therapy for Lymphoma
Not yet recruiting
  • Lymphoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-10-05
Oct 5, 2021
N
Safety Study of Cord Blood Units for Stem Cell Transplants
Recruiting
  • Aplastic Anemia
  • +3 more
  • Cord Blood Units
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-10-14
Oct 14, 2021
J
A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma
Active, not recruiting
  • Lymphoma
  • Gilbert, Arizona
  • +134 more
2021-10-14
Oct 14, 2021
U
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Recruiting
  • Chronic Myeloproliferative Disorders
  • +7 more
  • biologic sample preservation procedure
  • cytology specimen collection procedure
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
2021-10-14
Oct 14, 2021
N
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
Recruiting
  • Solid Tumors
  • Lymphoma
  • Bethesda, Maryland
  • +1 more
2021-10-14
Oct 14, 2021
R
Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma
Enrolling by invitation
  • Lymphoma
  • Total body PET/CT (uExplorer)
  • Shanghai, Shanghai, China
    Shanghai jiaotong University School of Medicine, Renji Hospital
2021-10-14
Oct 14, 2021
N
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1383 more
2021-10-14
Oct 14, 2021
N
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Active, not recruiting
  • Melanoma
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-10-14
    Oct 14, 2021
    D
    UPLYFT For Lymphoma Survivors
    Not yet recruiting
    • Lymphoma
    • Survivorship
    • Interview with Clinicians
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    2021-10-05
    Oct 5, 2021
    S
    A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HLX26 Monoclonal Antibody Injection in Patients With Advanced/Metastatic Solid Tumor or Lymphoma
    Recruiting
    • Solid Tumor, Adult
    • Lymphoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    2021-10-13
    Oct 13, 2021
    I
    A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)
    Active, not recruiting
    • Lymphoma
    • Birmingham, Alabama
    • +85 more
    2021-10-06
    Oct 6, 2021
    N
    Continuous Infusion of rhIL-15 for Adults With Advanced Cancer - 2019
    Completed
    • Lymphoma
    • Carcinoma
    • rh IL-15 (10 DAYS)
    • rh IL-15 (5 DAYS)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-10-13
    Oct 13, 2021
    S
    Medical Treatment Decision Making Using Adaptive Conjoint Analysis - 2019
    Terminated
    • Cancer
    • +4 more
      • Memphis, Tennessee
        St. Jude Children's Research Hospital
      2021-10-13
      Oct 13, 2021
      U
      Endobronchial Diagnosis of Lymphoma
      Recruiting
      • Lymphoma
      • Endobronchial ultrasound guided miniforceps biopsy and transbronchial needle aspiration
      • Caen, Normandy, France
        CaenUH
      2021-09-29
      Sep 29, 2021
      M
      Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
      Active, not recruiting
      • Solid Tumors
      • Lymphoma
      • Birmingham, Alabama
      • +18 more
      2021-10-05
      Oct 5, 2021
      D
      Axi-cel in CNS Lymphoma
      Recruiting
      • Lymphoma
      • Lymphoma Cns
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      2021-10-12
      Oct 12, 2021
      C
      Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
      Recruiting
      • Lymphoma
      • Calgary, Alberta, Canada
      • +14 more
      2021-10-12
      Oct 12, 2021
      S
      Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas - 2020
      Completed
      Has Results
      • Metastatic Cancer
      • +2 more
      • Grand Rapids, Michigan
      • +3 more
      2021-10-11
      Oct 11, 2021
      L
      Phase 1 Study to Determine the MTD, Safety, Tolerability, PK and Preliminary Anti-tumor Effects of LNS8801alone and With Pembrolizumab
      Recruiting
      • Solid Tumor, Adult
      • Lymphoma
      • LNS8801 -Small molecule, orally bioavailable, selective agonist of GPER
      • Pembrolizumab - anti-PD-1 antibody
      • Los Angeles, California
      • +7 more
      2021-10-11
      Oct 11, 2021
      C
      Study of ACTR707 in Combination With Rituximab in Subjects With Relapsed or Refractory B Cell Lymphoma - 2020
      Terminated
      • Lymphoma
      • ACTR707
      • rituximab
      • Gilbert, Arizona
      • +10 more
      2021-10-04
      Oct 4, 2021
      M
      Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant - 2020
      Terminated
      • Acute Leukemia
      • +3 more
      • Nivolumab (.25 mg/kg)
      • +2 more
      • Milwaukee, Wisconsin
        Froedtert Hospital and the Medical College of Wisconsin
      2021-10-04
      Oct 4, 2021
      I
      Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)
      Active, not recruiting
      • Lymphoma
      • Gilbert, Arizona
      • +20 more
      2021-10-08
      Oct 8, 2021
      M
      Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
      Recruiting
      • Lymphoma
      • +4 more
        • Basking Ridge, New Jersey
        • +5 more
        2021-10-07
        Oct 7, 2021
        T
        A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
        Recruiting
        • Lymphoma
        • No Intervention
        • Xiamen, Fujian, China
        • +13 more
        2021-10-07
        Oct 7, 2021
        W
        Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autograft (APA²)
        Recruiting
        • Myeloma
        • +2 more
        • Adapted Physical Activity
        • Angers, France
        • +1 more
        2021-10-07
        Oct 7, 2021